Imprimis NJOF, LLC recalls
Every recall we track for Imprimis NJOF, LLC — 21 in all, from 2020–2025 — plus the complaints and injury reports the public filed about them. 4 are rated “stop using now”.
Recalls per year, by danger level
Recalls from Imprimis NJOF, LLC peaked in 2024 (10); 21 since 2017. 19% rated “stop using now”.
All FDA recall records for Imprimis NJOF, LLC since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 1 | 0 | 1 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 1 | 2 | 0 | 3 |
| 2024 | 2 | 1 | 4 | 3 | 10 |
| 2025 | 2 | 1 | 4 | 0 | 7 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
Most common reasons for Imprimis NJOF, LLC recalls
What to do if you have a recalled Imprimis NJOF, LLC product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Imprimis NJOF, LLC recalls
14 shown- Stop using nowDrug
Imprimis NJOF, LLC recalls Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF,
Imprimis recalls Tri-Moxi+ eye injections due to glass particles. Stop using if you have the specific lot numbers listed. Contact for details.
ImprimisDec 18, 2025 - Lower riskDrug
Imprimis NJOF, LLC recalls Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office
Imprimis NJOF recalls specific lots of Klarity-C Cyclosporine eye drops due to subpotent drug levels. This compounded medication requires immediate action for safety.
Imprimis NJOFOct 20, 2025 - Lower riskDrug
Imprimis NJOF, LLC recalls Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per
Imprimis recalls specific ophthalmic solution due to subpotent drug levels. This may not work as intended for eye treatments. Check your product details to see if affected.
ImprimisJul 9, 2025 - Lower riskDrug
Imprimis NJOF, LLC recalls Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5 mL fill in 15
Imprimis recalls ophthalmic solution with subpotent drug levels. Product may not work as intended. Check NDC 71384-733-05 and lot 24OCT041 for affected items.
ImprimisFeb 24, 2025 - Stop using nowDrug
Imprimis NJOF, LLC recalls Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1% 5.5mL, Rx Only, This is a compounded drug.
Imprimis NJOF recalls Klarity-C (cyclosporine) eye drops due to lack of sterility assurance. This compounded drug may cause infection if used. Stop using and contact your doctor.
Imprimis NJOFMay 14, 2024 - UnratedDrug
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intraocular Injection,
Imprimis recalls specific epinephrine-lidocaine vials for intraocular use due to lack of sterility assurance. Affected vials have unique lot numbers and expiration dates. Consumers should contact the manufacturer for details.
ImprimisMay 14, 2024 - Stop using nowDrug
Imprimis NJOF, LLC recalls Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL and 0.4 mg/mL), Preservative-Free, 1mL Single-Use vials for
Imprimis NJOF recalls 38,060 vials of Dexamethasone-Moxifloxacin-Ketorolac due to lack of sterility assurance. Check lot numbers and expiration dates.
Imprimis NJOFMay 14, 2024 - Use cautionDrug
Imprimis NJOF, LLC recalls Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantity: 20mL, Rx Only,
Imprimis NJOF recalls compounded eye drops due to lack of sterility assurance. Check lot 23NOV018, exp 6/17/24.
Imprimis NJOFMay 14, 2024 - Lower riskDrug
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx only, Imprimis NJOF,
Imprimis NJOF recalls specific epinephrine-lidocaine vials for assay inaccuracies. These prescription-only vials may not contain the correct medication concentration.
Imprimis NJOFApr 10, 2024 - Lower riskDrug
Imprimis NJOF, LLC recalls Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By:
Imprimis NJOF recalls Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac eye drops due to subpotent drug levels. This may affect safety and effectiveness of treatment.
Imprimis NJOFApr 10, 2024 - Lower riskDrug
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC
Imprimis recalls epinephrine-lidocaine eye injections due to potential underactive epinephrine. Affected lots may not work properly during eye procedures. Contact FDA for adverse events.
Imprimis NJOFOct 3, 2023 - Use cautionDrug
Imprimis NJOF, LLC recalls MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution Drops 1% - 0.5% - 2.5%
Imprimis NJOF recalls MYDRIATIC-4 ophthalmic solution drops because Ketorolac levels are below label claim. Check lot numbers and expiration dates.
Imprimis NJOFSep 20, 2023 - Lower riskDrug
Imprimis NJOF, LLC recalls Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West,
Imprimis recalls 5mL eye drop bottles with subpotent Bromfenac levels. These drops may not provide proper treatment for eye infections. Stop using immediately if you have the affected lot numbers.
ImprimisAug 10, 2023 - Lower riskDrug
Imprimis NJOF, LLC recalls Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46
Imprimis recalls 13 vials of Dexamethasone-Moxifloxacin injection due to faulty crimps causing potential contamination. Affected lots: 20JUN010 (expiring 5/12/21).
ImprimisDec 17, 2020
Imprimis NJOF, LLC recall questions
How many recalls has Imprimis NJOF, LLC had?
21 recalls from Imprimis NJOF, LLC are on record with U.S. safety agencies, from 2020–2025.
What is the most recent Imprimis NJOF, LLC recall?
Imprimis NJOF, LLC recalls Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF,, dated Dec 18, 2025. Every Imprimis NJOF, LLC recall is listed on this page, newest first.
Why are Imprimis NJOF, LLC products recalled?
The most common reasons on record: Lack of Assurance of Sterility (8); Presence of particulate matter - Glass like particles. (3); Subpotent Drug (2); Sub-Potent Drug: Subpotent assay results during stability testing. (2).
What should I do if I have a recalled Imprimis NJOF, LLC product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Imprimis NJOF, LLC recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.